Imanis Life Sciences Announces Peer-Reviewed Publication of Data on Quantitative Virus Neutralization Assay IMMUNO-COV™ ROCHESTER, Minn., June 22, 2021 (GLOBE NEWSWIRE) -- Imanis Life Sciences (“Imanis” or “The Company”) today announced the publication of a peer-reviewed scientific paper detailing its latest improved...

Imanis Life Sciences Announces New Data from Clinical Assay Measuring SARS-CoV-2 Neutralizing Antibodies Clinical validation of high throughput assay that provides numeric results (titer) of neutralizing antibodiesFormer COVID-19 patients, in a small preliminary sample set, saw marked decline in...

Imanis Life Sciences Announces Improvements and Increased Capacity of IMMUNO-COV™, a First-in-Class Neutralizing Antibody Test for COVID-19 ROCHESTER, Minn., Nov. 19, 2020 (GLOBE NEWSWIRE) -- Imanis Life Sciences, LLC (“Imanis” or “The Company”) announced today that it has completed validation of its latest improved IMMUNO-COVTM...